Pharmacokinetics of buccal mucosal administration of fentanyl in a carboxymethylcellulose gel compared with IV administration in dogs

Veterinary Therapeutics

Volumn 9, Issue 3, 2008, Pages 201-211

  Little, Amy A ^a,b   Krotscheck, Ursula ^a   Boothe, Dawn M ^c   Erb, Hollis N ^a  

^a Department of Molecular Biology and Genetics   (United States)

^b VCA Veterinary Specialty Center of Seattle   (United States)

^c AUBURN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYMETHYLCELLULOSE; FENTANYL; NARCOTIC ANALGESIC AGENT;

ABSORPTION; ANIMAL; ANIMAL DISEASE; AREA UNDER THE CURVE; ARTICLE; BIOAVAILABILITY; BLOOD; BUCCAL DRUG ADMINISTRATION; CROSSOVER PROCEDURE; DOG; DRUG ADMINISTRATION ROUTE; FEMALE; GEL; INTRAVENOUS DRUG ADMINISTRATION; MALE; METABOLISM; MOUTH MUCOSA; RANDOMIZATION;

ABSORPTION; ADMINISTRATION, BUCCAL; ANALGESICS, OPIOID; ANIMALS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CARBOXYMETHYLCELLULOSE; CROSS-OVER STUDIES; DOGS; DRUG ADMINISTRATION ROUTES; FEMALE; FENTANYL; GELS; INJECTIONS, INTRAVENOUS; MALE; MOUTH MUCOSA; RANDOM ALLOCATION;

CANIS FAMILIARIS;

EID: 53949093222     PISSN: 15283593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Streisand JB, Varvel JR, Stanski DR, et al. Absorption and bioavailability of oral transmucosal fentanyl citrace. Anesthesiology 1991;75:223-229.
2. Bullingham RE, McQuay HJ, Porter EJ, et al. Sublingual buprenorphine used postoperatively: ten hour plasma drug concentration analysis. Br J Clin Pharmacol 1982;13:665-673.
3. Labroo RB, Paine MF, Thummel KE, Kharasch ED. Fentanyl metabolism by human hepatic and intestinal cytochrome P450 3A4: implications for interindividual variability in disposition, efficacy, and drug interactions. Drug Metab Dispos 1997;25:1072-1080.
4. Nath RP, Upton RA, Everhart ET et al. Buprenorphine pharmacokinetics: relative bioavailability of sublingual tablet and liquid formulations. J Clin Pharmacol 1999;39:619-623.
5. Varvel JR, Shafer SL, Hwang SS, et al. Absorption characteristics of transdermally administered fentanyl. Anesthesiology 1989;70:928-934.
6. Robinson TM, Kruse-Elliott KT, Markel MD, et al. A comparison of transdermal fentanyl versus epidural morphine for analgesia in dogs undergoing major orthopedic surgery. JAAHA 1999;35:95-100.
7. Kyles AE, Hardie EM, Hansen BD, Papich MG. Comparison of transdermal fentanyl and intramuscular oxymorphone on post-operative behaviour after ovariohysterectomy in dogs. Res Vet Sci 1998;65:245-251.
8. Gibaldi M, Kanig JL. Absorption of drugs through the oral mucosa. J Oral Ther Pbarmacol 1965;31:440-450.
9. Zimmer R, Ashburn MA. Noninvasive drug delivery. Comp Ther 2001;27:293-301.
10. Lennernas B, Hedner T Holmberg M, et al. Pharmacokinetics and tolerability of different doses of fentanyl following sublingual administration of a rapidly dissolving tablet to cancer patients: a new approach to treatment of incident pain. Br J Clin Pharmacol 2005; 59:249-253.
11. Bredenberg S, Duberg M, Lenneras B, et al. In vitro and in vivo evaluation of a new sublingual tablet system for rapid oromucosal absorption using fentanyl citrate as the active substance. Eur J Pharm Sci 2003;20:327-334.
12. Barsuhn CL, Olanoff LS, Gleason DD, et al. Human buccal absorption of flurbiprofen. Clin Pharmacol Ther 1988;44:225-231.
13. Hunter RP, Isaza R, Carpenter JW, Koch DE. Clinical effects and plasma concentrations of fentanyl after transmucosal administration in three species of great ape. J Zoo Wildl Med 2004;35:162-166.
14. Robertson SA, Taylor PM, Sear JW. Systemic uptake of buprenorphine by cats after oral mucosal administration. Vet Rec 2003;152:675-678.
15. Krotscheck U. Transmucosal administration of fentanyl in dogs: a pilot study. Unpublished manuscript, 2002.
16. Michiels M, Hendriks R, Heykants J. A sensitive radioimmunoassay for fentanyl. Plasma level in dogs and man. Eur J Clin Pharmacol 1977;12:153-158.
17. Streisand JB, Zhang J, Niu S, et al. Buccal absorption of fentanyl is pH-dependent in dogs. Anesthesiology 1995;82:759-764.
18. Roy SD, Flynn GL. Solubility and related physicochemical properties of narcotic analgesics. Pharm Res 1988;5:580-586.
19. Burcon AW, Driver LC, Mendoza TR, Syed G. Oral transmucosal fentanyl citrate in the outpatient management of severe cancer pain crises: a retrospective case series. Clin J Pain 2004;20:195-197.
20. Christie JM, Simmonds M, Patt R, et al. Dose-titration, multicenter study of oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients using transdermal fentanyl for persistent pain. J Clin Oncol 1998;16:3238-3245.
21. Portenoy RK, Taylor D, Messina J, Tremmel L. A randomized, placebo-controlled study of fentanyl buccal tablet for breakthrough pain in opioid-treated patients with cancer. Clin J Pain 2006;22:805-811.
22. Robert R, Brack A, Blakeney P, et al. A double-blind study of the analgesic efficacy of oral transmucosal fentanyl citrate and oral morphine in pediatric patients undergoing burn dressing change and tubbing. J Burn Care Rehabil 2003;24:351-355.
23. Sharar SR, Bratton SL, Carrougher GJ, et al. A comparison of oral transmucosal fentanyl citrate and oral hydromorphone for inpatient pediatric burn wound care analgesia. J Burn Care Rehabil 1998;19:516-521.
24. Weinberg DS, Inturrisi CE, Reidenberg B, et al. Sublingual absorption of selected opioid analgesics. Clin Pharmacol Ther 1988;44:335-342.
25. Darwish M, Tempero K, Kirby M, Thompson J. Pharmacokinetics and dose proportionality of fentanyl effervescent buccal tablets in healthy volunteers. Clin Pharmacokinet 2005;44:1279-1286.
26. Darwish M, Kirby M, Robertson P, et al. Pharmacokinetic properties of fentanyl effervescent buccal tablets: a phase I, open-label, crossover study of single-dose 100, 200, 400, and 800 mcg in healthy adult volunteers. Clin Ther 2006;28:707-714.
27. Darwish M, Kirby M, Robertson P, et al. Comparison of equivalent doses of fentanyl buccal tablets and arteriovenous differences in fentanyl pharmacokinetics. Clin Pharmacokinet 2006;45:843-850.
28. Holley FO, Van Stennis C. Post-operative analgesia with fentanyl; pharmacokinetics and pharmacodynamics of constant-rate I.V. and transdermal delivery. Br J Anaesth 1988;60:608-613.
29. Dsida RM, Wheeler M, Birmingham PK, et al. Pre-medication of pediatric tonsillectomy patients with oral transmucosal fentanyl citrate. Anesth Analg 1998;86:66-70.
30. Streisand JB, Busch MA, Egan TD, et al. Dose proportionality and pharmacokinetics of oral transmucosal fentanyl citrate. Anesthesiology 1998;88:305-309.
31. Diaz del Consuelo I, Falson F, Guy RH, Jacques Y. Ex vivo evaluation of bioadhesive films for buccal delivery of fentanyl. J Control Release 2007;122:135-140.
32. Murphy MR, Olson WA, Hug CCJ. Pharmacokinetics of 3H-fentanyl in the dog anesthetized with enflurane. Anesthesiology 1979;50:13-19.
33. Murphy MR, Hug CC,Jr, McClain DA. Dose-independent pharmacokinetics of fentanyl. Anesthesiology 1983;59:537-540.
34. Schumann H, Erickson T, Thompson TM, et al. Fentanyl epidemic in Chicago, Illinois and surrounding Cook County. J Toxicol Clin Toxicol 2008;46:501-506.
35. Thompson JG, Baker AM, Bracey AH, et al. Fentanyl concentrations in 23 postmortem cases from the Hennepin County medical examiner's office. J Forensic Sci 2007;52:978-981.
36. Boothe DM. Veterinary compounding in small animals: a clinical pharmacologist's perspective. Vet Clin Small Anim 2006;36:1129-1173.
37. Animal Health Institute, American Veterinary Medical Association, American Veterinary Distributors Association: Veterinary Compounding. Accessed August 2008 at www.avma.org/issues/drugs /compounding/veterinary_compounding_brochure.asp.